Depression-related anhedonic behaviors caused by immobilization stress: A comparison with nicotine-induced depression-like behavioral alterations and effects of nicotine and/or "antidepressant" drugs

Journal of Toxicological Sciences

Volumn 36, Issue 1, 2011, Pages 31-41

  Hayase, Tamaki ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Anhedonia; Antidepressants; Cannabinoids; Depression; Immobilization stress; Nicotine

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CANNABINOID RECEPTOR; CLOMIPRAMINE; FLUVOXAMINE; MONOAMINE; NICOTINE; SUCROSE;

ANHEDONIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG ACTIVITY; DRUG EFFECT; EXPERIMENTAL TEST; FORCED SWIMMING TEST; HOPELESSNESS; IMMOBILIZATION STRESS; MALE; MOUSE; NONHUMAN; REPEAT PROCEDURE; SUGAR INTAKE;

MUS;

EID: 79551604950     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.36.31     Document Type: Article

References (50)

1. Adamczyk, P., Gołda, A., McCreary, A.C., Filip, M. and Przegaliński, E. (2008): Activation of endocannabinoid transmission induces antidepressant-like effects in rats. J. Physiol. Pharmacol., 59, 217-228.
2. Alves, S.H., Pinheiro, G., Motta, V., Landeira-Fernandez, J. and Cruz, A.P. (2004): Anxiogenic effects in the rat elevated plusmaze of 5-HT (2C) agonists into ventral but not dorsal hippocampus. Behav. Pharmacol., 15, 37-43.
3. Armario, A., Gil, M, Marti, J., Pol, O. and Balasch, J. (1991): Influence of various acute stressors on the activity of adult male rats in a holeboard and in the forced swim test. Pharmacol. Biochem. Behav, 39, 373-377.
4. Consoli, D., Fedotova, J., Micale, V, Sapronov, N.S. and Drago, F. (2005): Stressors affect the response of male and female rats to clomipramine in a model of behavioral despair (forced swim test). Eur. J. Pharmacol., 520, 100-107.
5. Cruz, F.C., DeLucia, R. and Planeta, C.S. (2008): Effects of chronic stress on nicotine-induced locomotor activity and corticosterone release in adult and adolescent rats. Addict. Biol., 13, 63-69.
6. Dawkins, L., Powell, J.H., Pickering, A., Powell, J. and West, R. (2009): Patterns of change in withdrawal symptoms, desire to smoke, reward motivation and response inhibition across 3 months of smoking abstinence. Addiction, 104, 850-858.
7. Devane, W.A., Dysarz, F.A.3rd., Johnson, M.R., Melvin, L.S. and Howlett, A.C. (1988): Determination and characterization of a cannabinoid receptor in rat brain. Mol. Pharmacol., 34, 605-613.
8. Felder, C.C., Briley, E.M., Axelrod, J., Simpson, J.T., Mackie, K. and Devane, W.A. (1993): Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction. Proc. Natl. Acad. Sci. USA, 90, 7656-7660.
9. Gobbi, G., Bambico, F.R., Mangieri, R., Bortolato, M., Campolongo, P., Solinas, M., Cassano, T., Morgese, M.G., Debonnel, G., Duranti, A., Tontini, A., Tarzia, G, Mor, M., Trezza, V., Goldberg, S.R., Cuomo, V. and Piomelli, D. (2005): Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. Proc. Natl. Acad. Sci. USA, 102, 18620-18625.
10. Goshen, I., Kreisel, T., Ben-Menachem-Zidon, O., Licht, T., Weidenfeld, J., Ben-Hur, T. and Yirmiya, R. (2008): Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression. Mol. Psychiatry, 13, 717-728.
11. Hayase, T., Yamamoto, Y. and Yamamoto, K. (2000): Stress-related behavioral alterations accompanying cocaine toxicity: the effects of mixed opioid drugs. Jpn. J. Alcohol & Drug Dependence, 35, 402-414.
12. Hayase, T. (2007): Chronologically overlapping occurrences of nicotine-induced anxiety- and depression-related behavioral symptoms: effects of anxiolytic and cannabinoid drugs. BMC Neurosci., 8, 76.
13. Hayase, T. (2008): Nicotine (NC)-induced "depressive" behavioral symptoms and effects of antidepressants including cannabinoids (CBs). J. Toxicol. Sci., 33, 555-564.
14. Jayatissa, M.N., Henningsen, K., Nikolajsen, G., West, M.J. and Wiborg, O. (2010): A reduced number of hippocampal granule cells does not associate with an anhedonia-like phenotype in a rat chronic mild stress model of depression. Stress, 13, 95-105.
15. Jiang, W., Zhang, Y., Xiao, L., Van Cleemput, J., Ji, S.P., Bai, G. and Zhang, X. (2005): Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and anti-depressant-like effects. J. Clin. Invest., 115, 3104-3116.
16. Lerman, C., Audrain, J., Orleans, C.T., Boyd, R., Gold, K., Main, D. and Caporaso, N. (1996): Investigation of mechanisms linking depressed mood to nicotine dependence. Addict. Behav., 21, 9-19.
17. Leventhal, A.M., Ramsey, S.E., Brown, R.A., LaChance, H.R. and Kahler, C.W. (2008): Dimensions of depressive symptoms and smoking cessation. Nicotine Tob. Res., 10, 507-517.
18. Leventhal, A.M., Waters, A.J., Kahler, C.W., Ray, L.A. and Sussman, S. (2009): Relations between anhedonia and smoking motivation. Nicotine Tob. Res., 11, 1047-1054.
19. Liu, Q., Yu, J., Mao-Ying, Q.L., Mi, W.L., Li, B., Wang, Y.Q., Wang, J. and Wu, G.C. (2008): Repeated clomipramine treatment reversed the inhibition of cell proliferation in adult hippocampus induced by chronic unpredictable stress. Pharmacogenomics J., 8, 375-383.
20. Maldonado, R. and Berrendero, F. (2010): Endogenous cannabinoid and opioid systems and their role in nicotine addiction. Curr. Drug Targets, 11, 440-449.
21. Mannucci, C., Tedesco, M., Bellomo, M., Caputi, A.P. and Calapai, G. (2006): Long-term effects of nicotine on the forced swimming test in mice: an experimental model for the study of depression caused by smoke. Neurochem. Int., 49, 481-486.
22. Merritt, L.L., Martin, B.R., Walters, C., Lichtman, A.H. and Damaj, M.I. (2008): The endogenous cannabinoid system modulates nicotine reward and dependence. J. Pharmacol. Exp. Ther., 326, 483-492.
23. Miller, H.L., Delgado, P.L., Salomon, R.M., Berman, R., Krystal, J.H., Heninger, G.R. and Charney, D.S. (1996): Clinical and biochemical effects of catecholamine depletion on antidepressant-induced remission of depression. Arch. Gen. Psychiatry, 53, 117-128.
24. Morse, D.E. (1989): Neuroendocrine responses to nicotine and stress: enhancement of peripheral stress responses by the administration of nicotine. Psychopharmacology (Berl.), 98, 539-543.
25. Parrott, A.C. (2004): Heightened stress and depression follow cigarette smoking. Psychol. Rep., 94, 33-34.
26. Paterson, N.E., Balfour, D.J. and Markou, A. (2007): Chronic bupropion attenuated the anhedonic component of nicotine withdrawal in rats via inhibition of dopamine reuptake in the nucleus accumbens shell. Eur. J. Neurosci., 25, 3099-3108.
27. Perona, M.T., Waters, S., Hall, F.S., Sora, I., Lesch, K.P., Murphy, D.L., Caron, M. and Uhl, G.R. (2008): Animal models of depression in dopamine, serotonin, and norepinephrine transporter knockout mice: prominent effects of dopamine transporter deletions. Behav. Pharmacol., 19, 566-574.
28. Pertwee, R.G. (2007): GPR55: a new member of the cannabinoid receptor clan? Br. J. Pharmacol., 152, 984-986.
29. Picciotto, M.R. (1998): Common aspects of the action of nicotine and other drugs of abuse. Drug Alcohol Depend., 51, 165-172.
30. Picciotto, M.R., Brunzell, D.H. and Caldarone, BJ. (2002): Effect of nicotine and nicotinic receptors on anxiety and depression. Neuroreport, 13, 1097-1106. (Pubitemid 34722033)
31. Porsolt, R.D., Le Pichon, M. and Jalfre, M. (1977): Depression: a new animal model sensitive to antidepressant treatments. Nature, 266, 730-732.
32. Porter, A.C., Sauer, J.M., Knierman, M.D., Becker, G.W., Berna, M.J., Bao, J., Nomikos, G.G., Carter, P., Bymaster, F.P., Leese, A.B. and Felder, C.C. (2002): Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor. J. Pharmacol. Exp. Ther., 301, 1020-1024.
33. Renard, C.E., Dailly, E., David, D.J., Hascoet, M. and Bourin, M. (2003): Monoamine metabolism changes following the mouse forced swimming test but not the tail suspension test. Fundam. Clin. Pharmacol., 17, 449-455.
34. Rygula, R., Abumaria, N., Flügge, G., Hiemke, C., Fuchs, E., Rüther, E. and Havemann-Reinecke, U. (2006): Citalopram counteracts depressive-like symptoms evoked by chronic social stress in rats. Behav. Pharmacol., 17, 19-29.
35. Salín-Pascual, R.J., Rosas, M, Jimenez-Genchi, A., Rivera-Meza, B.L. and Delgado-Parra, V. (1996): Antidepressant effect of transdermal nicotine patches in nonsmoking patients with major depression. J. Clin. Psychiatry, 57, 387-389.
36. Serova, L., Danailov, E., Chamas, F. and Sabban, E.L. (1999): Nicotine infusion modulates immobilization stress-triggered induction of gene expression of rat catecholamine biosynthetic enzymes. J. Pharmacol. Exp. Ther., 291, 884-892.
37. Snaith, P. (1992): Anhedonia: exclusion from the pleasure dome. BMJ, 305, 134.
38. Solberg, L.C., Horton, T.H. and Turek, F.W. (1999): Circadian rhythms and depression: effects of exercise in an animal model. Am. J. Physiol., 276, R152-R161.
39. Solich, J., Pałach, P., Budziszewska, B. and Dziedzicka- Wasylewska, M. (2008): Effect of two behavioral tests on corticosterone level in plasma of mice lacking the noradrenaline transporter. Pharmacol. Rep., 60, 1008-1013.
40. Steiner, M.A., Marsicano, G., Nestler, E.J., Holsboer, F., Lutz, B. and Wotjak, C.T. (2008): Antidepressant-like behavioral effects of impaired cannabinoid receptor type 1 signaling coincide with exaggerated corticosterone secretion in mice. Psychoneuroendocrinology, 33, 54-67.
41. Steru, L., Chermat, R., Thierry, B. and Simon, P. (1985): The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl.), 85, 367-370.
42. Strekalova, T, Gorenkova, N, Schunk, E., Dolgov, O. and Bartsch, D. (2006): Selective effects of citalopram in a mouse model of stress-induced anhedonia with a control for chronic stress. Behav. Pharmacol., 17, 271-287.
43. Takahashi, H., Takada, Y., Nagai, N., Urano, T. and Takada, A. (1998): Effects of nicotine and footshock stress on dopamine release in the striatum and nucleus accumbens. Brain Res. Bull., 45, 157-162.
44. Tani, Y., Saito, K., Tsuneyoshi, A., Imoto, M. and Ohno, T. (1997): Nicotinic acetylcholine receptor (nACh-R) agonist-induced changes in brain monoamine turnover in mice. Psychopharmacology (Berl.), 129, 225-232. (Pubitemid 27085392)
45. Tizabi, Y., Overstreet, D.H., Rezvani, A.H., Louis, V.A., Clark, E.Jr., Janowsky, D.S. and Kling, M.A. (1999): Antidepressant effects of nicotine in an animal model of depression. Psychopharmacology (Berl.), 142, 193-199.
46. Ushijima, K., Sakaguchi, H., Sato, Y., To, H., Koyanagi, S., Higuchi, S. and Ohdo, S. (2005): Chronopharmacological study of antidepressants in forced swimming test of mice. J. Pharmacol. Exp. Ther., 315, 764-770.
47. Vázquez-Palacios, G., Bonilla-Jaime, H. and Velazquez-Moctezuma, J. (2004): Antidepressant-like effects of the acute and chronic administration of nicotine in the rat forced swimming test and its interaction with fluoxetine. Pharmacol. Biochem. Behav., 78, 165-169.
48. West, R.J., Hajek, P. and Belcher, M. (1989): Severity of withdrawal symptoms as a predictor of outcome of an attempt to quit smoking. Psychol. Med., 19, 981-985.
49. Wong, M.L. and Licinio, J. (2004): From monoamines to genomic targets: a paradigm shift for drug discovery in depression. Nat. Rev. Drug Discov, 3, 136-151.
50. Yoshida, T., Sakane, N., Umekawa, T. and Kondo, M. (1994): Effect of nicotine on sympathetic nervous system activity of mice subjected to immobilization stress. Physiol. Behav, 55, 53-57.